5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.
James E. Rothman, insider at Berkeley Lights
James E. Rothman Insider Alerts

Get notified the next time James E. Rothman buys or sells Berkeley Lights stock. Enter your email address below to get our daily insider buying and selling report.

James E. Rothman Insider Information

Director of Berkeley Lights
James E. Rothman founded ARIAD Pharmaceuticals, Inc. Dr. Rothman is Senior Advisor at Arsenal Capital Management LP. He is also on the board of TractManager, Inc., Berkeley Lights, Inc. and WCG Clinical, Inc. and Professor & Director-Nanobiology Institute at Yale School of Medicine.

James E. Rothman previously was Advisor at Johnson & Johnson, Consultant at Eli Lilly & Co., Consultant at GlaxoSmithKline (New Jersey), Strategic Advisor at The Courtagen Group LLC, Chief Scientist at General Electric Healthcare Technologies, Inc., Consultant at Genentech, Inc., Advisor at Amersham Plc, Professor & Director-Sulzberger Genome at The Trustees of Columbia University in The City of New York, Professor at Stanford University, Professor at Princeton University and Vice Chairman & Chairman-Cellular Biochemistry at Memorial Sloan-Kettering Cancer Center.

Dr. Rothman received a doctorate from Harvard University and an undergraduate degree from Yale University.

What is James E. Rothman's net worth?

The estimated net worth of James E. Rothman is at least $1.27 million as of March 5th, 2021. Dr. Rothman owns 138,845 shares of Berkeley Lights stock worth more than $1,273,209 as of January 20th. This net worth evaluation does not reflect any other assets that Dr. Rothman may own. Learn More.

How do I contact James E. Rothman?

The corporate mailing address for Dr. Rothman and other Berkeley Lights executives is 5858 HORTON STREET SUITE 320, EMERYVILLE CA, 94608. Berkeley Lights can also be reached via phone at 510-858-2855 and via email at [email protected]

Has James E. Rothman been buying or selling shares of Berkeley Lights?

James E. Rothman has not been actively trading shares of Berkeley Lights over the course of the past ninety days. Most recently, on Monday, November 8th, James Rothman bought 4,000 shares of Berkeley Lights stock. The stock was acquired at an average cost of $24.35 per share, with a total value of $97,400.00.

Who are Berkeley Lights' active insiders?

Berkeley Lights' insider roster includes Keith Breinlinger (Insider), Eric Hobbs (CEO), Shaun Holt (CFO), Igor Khandros (Director), Gregory Lucier (Director), Michael Marks (Director), Stuart Merkadeau (General Counsel), Scott Olrich (COO), Matthew Rosinack (CAO), and James Rothman (Director).

Are insiders buying or selling shares of Berkeley Lights?

In the last twelve months, Berkeley Lights insiders bought shares 3 times. They purchased a total of 29,704 shares worth more than $803,001.60. In the last twelve months, insiders at the sold shares 48 times. They sold a total of 1,299,060 shares worth more than $66,183,140.19. The most recent insider tranaction occured on November, 8th when Director James Rothman bought 4,000 shares worth more than $97,400.00. Insiders at Berkeley Lights own 20.3 % of the company.

Information on this page was last updated on 11/8/2021.

James E. Rothman Insider Trading History at Berkeley Lights

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/8/2021Buy4,000$24.35$97,400.00View SEC Filing Icon  
3/5/2021Sell140,000$52.75$7,385,000.00138,845View SEC Filing Icon  
3/3/2021Sell72,000$60.20$4,334,400.00125,000View SEC Filing Icon  
See Full Table

James E. Rothman Buying and Selling Activity at Berkeley Lights

This chart shows James Rothman's buying and selling at Berkeley Lights by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Berkeley Lights Company Overview

Berkeley Lights logo
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.
Read More

Today's Range

Now: $9.17
Low: $9.11
High: $10.08

50 Day Range

MA: $18.14
Low: $9.17
High: $25.68

2 Week Range

Now: $9.17
Low: $9.05
High: $85.09

Volume

3,064,652 shs

Average Volume

3,077,638 shs

Market Capitalization

$618.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.95
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.